Simvastatin maintains lysosomal biogenesis and autophagic turnover by regulating TFEB in mouse microvascular endothelial cells, thereby preventing cardiovascular complications such as endothelial barrier dysfunction with endothelial hyperpermeability in models of obesity [30]. This evidence concerns the gene TFEB and obesity due to melanocortin 4 receptor deficiency.